PATENT CLAIM ANALYSIS

Application Number: 15881695
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "267000"]

Abstract:
Novel antiviral compounds of Formulae (I)-(III) are provided: The inventive compounds, pharmaceutical compositions thereof, and kits including the inventive compounds are useful for the prevention and treatment of infectious diseases caused by viruses, for example, by Flaviviridae virus (e.g., Dengue virus (DENV)), Kunjin virus, Japanese encephalitis virus, vesicular stomatitis virus (VSV), herpes simplex virus 1 (HSV-1), human cytomegalovirus (HCMV), poliovirus, Junin virus, Ebola virus, Marburg virus (MARV), Lassa fever virus (LASV), Venezuelan equine encephalitis virus (VEEV), or Rift Valley Fever virus (RVFV).

Claim (Index 13):
The compound of  claim 1 , wherein Ring C is aryl.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 86.0
- Lexical Diversity: 1.83824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14391638', '14436387', '15104132', '15847430', '15114895']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.845577987755036
- 35 USC 102 Novelty (BERT): 0.5973993260707525
- Combined Prediction Score: 0.8207601215866076
- Mean Citation Score: 556.130642
- Max Citation Score: 762.80365
- Similarity Product: 431.34415622482

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test